A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use.

Evelyne KestelynStephen AgabaJennifer Ilo Van NuilMireille UwinezaMarie Michelle UmulisaLambert MwambarangweJean Claude NdagijimanaIrith De BaetselierJozefien BuyzeThérèse DelvauxTania CrucittiVicky JespersJanneke H H M van de Wijgertnull null

Published in: PloS one (2018)

Intermittent and continuous NuvaRing® use were safe in Rwandan women and improved Nugent scores over time. However, attention should be paid to ring expulsions and to a potential increased risk of vaginal candidiasis.

Keyphrases

polycystic ovary syndrome
pregnancy outcomes
high intensity
working memory
antiretroviral therapy
study protocol
clinical trial
type diabetes
insulin resistance
randomized controlled trial
pregnant women
risk assessment
metabolic syndrome
human health
double blind